Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07327073 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of Exercise on Serum Irisin Levels and Clinical Parameters in Patients With Axial Spondyloarthritis.

StatusNot Yet Recruiting
PhaseNot applicable
Started2026-01-30
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 12, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-01-09
Study Status, Study Description, Arms and Interventions v1
Study description+20 characters
Axial spondyloarthritis (axSpA) is a chronic, inflammatory rheumatic disease affecting young peopleindividuals, with a prevalence of 0.3-1.4%. The leadingmain features of the disease areinclude inflammatory back pain, decreasedreduced joint mobility, and functional disability. FurthermoreIn addition, increasingaccumulating evidence inover recent years has showndemonstrated that inflammatory rheumatic diseases are also associated with an increased risk of cardiovascular disease. Exercise isconstitutes an important partcomponent of the treatmentmanagement of patients with inflammatory rheumatic [...]
2025-12-25
Original filing
This study aimed to investigate the effects of high-intensity intermittent exercise and moderate-intensity continuous exercise on serum irisin levels, disease activity, functional status, and quality of life in patients with axial spondyloarthritis.
Trial Details
NCT Number NCT07327073
Lead Sponsor Kirsehir Ahi Evran Universitesi
Collaborators: Scientific Research Projects
Conditions Ankylosing Spondylitis (AS), Irisin
Enrollment 75 participants
Start Date 2026-01-30
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-12